Marvin S. Antelman is the chemist and inventor named in the source dossiers as the developer and patent holder for applications of Tetrasilver Tetroxide (Ag₄O₄) (Ag₄O₄). He is the central figure of the dossier: the page's technical claims, its per-molecule power calculation, and its medical assertions all trace back to patents attributed to him.
Role in the dossier
Antelman is the attributed source of the compound's identity claim (a mixed-valence silver oxide), its proposed "electron-jumping compound" or "molecular battery" mechanism (see Electron Jumping Compound / Molecular Battery Claim), and its antimicrobial and water-disinfection applications. These are attributed assertions carried by the dossier and the cited patents; the wiki does not treat them as independently verified.
What the source attributes to him
- Authorship of Encyclopedia of Chemical Electrode Potentials (Plenum, 1982), cited within the quoted patent text for the value of the Ag(I) → Ag(II) oxidation potential (1.98 V, p. 88).
- Inventorship of a family of silver-based patents quoted on the page, covering molecular crystal devices for pharmaceuticals, trivalent and divalent silver water-treatment compositions, tetrasilver tetroxide skin treatments, and a claimed method of curing AIDS with tetrasilver tetroxide molecular crystal devices.
- The "electron jumping compound" / "molecular battery" framing of tetrasilver tetroxide, including the 6.4 × 10⁻¹⁹ watts-per-molecule figure.
Patents quoted on the page
| Patent | Title as quoted |
|---|---|
| US5336499 / US5571520 | Molecular Crystal Device for Pharmaceuticals |
| US5223149 | Trivalent Silver Water Treatment Compositions |
| US5211855 | Method of Treating Water Employing Tetrasilver Tetroxide Crystals |
| US6258385 | Tetrasilver Tetroxide Treatment for Skin Conditions |
| US5073382 | Divalent Silver Alkaline Bactericide Compositions |
| US5098582 | Divalent Silver Oxide Bactericides |
| US2006105057 / US2004022868 | Compositions using tetrasilver tetroxide and methods for management of skin conditions |
| US5017295 | Divalent Silver Bactericide for Water Treatment |
| US5676977 | Method of Curing AIDS with Tetrasilver Tetroxide Molecular Crystal Devices |
| WO9745133 | Use of Tetrasilver Tetroxide Molecular Crystals in the Preparation of a Medicament for Treatment of AIDS |
The page also links to a larger "ANTELMAN, Martin: TetraSilver TetrOxide Articles & Patents Database" hosted on the same site. Note that the page spells the surname "Antelman" in the patent attributions and gives the forename "Martin" in the database link title; the source does not resolve the discrepancy.
Evidentiary status
The source provides no biographical detail, no institutional affiliation, and no independent verification of any claim. The patents are assertions of novelty and utility; the page reproduces them for sale. The material associated with Antelman in these captures is patent text and promotional writing. Under the project's standing rule, a patent is not proof of effectiveness — see Patent as Evidence. No controlled trial or independent replication appears in the supplied material. See also Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence.
Source notes & attribution
- Rex Research, tetrasilver tetroxide dossier (native source: rexresearch/406c777e656cb9d0.md ).
- Rex Research, tetrasilver tetroxide patents dossier (native source: rexresearch/cf0017649975232a.md ). This capture is a patents page rather than the sales page and adds no new biographical detail beyond what the other captures carry.
- Related captures: Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Negative Kinshasa Result , Tetrasilver Tetroxide (TSTO): A Rex Research Sales-and-Patent Dossier , Tetrasilver Tetroxide: A Third Rex Research Capture (Variant Record) .
- https://rexresearch.com/AntelmanTSTO/TSTOAd.html
- https://rexresearch.com/tetrasilver/TSTOPatents.html